Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Cells in the Treatment of Moderate and Severe Intrauterine Adhesions

NCT04232592 is registered in ClinicalTrials.gov with Qi Zhou as lead sponsor.

NCT NCT04232592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Safety Study of Human Embryonic Stem Cell Derived Mesenchymal Cells in the Treatment of Moderate and Severe Intrauterine Adhesions
Lead sponsor
Qi Zhou
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2020
Completion date
January 31, 2022
Enrollment
32 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intrauterine adhesion